Development of a clinical prediction model for pathological upgrading in low-grade squamous intraepithelial lesions following cervical conization

被引:0
作者
Peng, Xinrui [1 ,2 ]
Wan, Jiayuan [1 ]
Wang, Yafei [1 ]
Wang, Liqun [1 ]
Wang, Liqun [1 ]
机构
[1] Bengbu Med Coll, Affiliated Hosp 1, Dept Gynecol, Bengbu, Anhui, Peoples R China
[2] Nanjing Gulou Hosp Grp Suqian Hosp, Dept Gynecol, Suqian, Jiangsu, Peoples R China
关键词
Low-grade squamous intraepithelial lesion; Cervical conization; Pathologic progression; Clinical prediction model; MANAGEMENT; NEOPLASIA; WOMEN; HPV;
D O I
10.25259/Cytojournal_7_2024
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: This study aimed to identify key factors influencing post-operative pathologic escalation in Chinese women with histologic cervical low-grade squamous intraepithelial lesions (LSILs) undergoing cervical conization and construct a predictive nomogram model. Material and Methods: A retrospective analysis was conducted on 107 patients with LSIL from Bengbu City, Anhui Province, China, who underwent cervical conization at the First Affiliated Hospital of Bengbu Medical College from January 2019 to January 2023. Patients were categorized into groups based on post-operative pathological upgrade. Univariate and multivariate logistic regression analyses identified independent risk factors. A nomogram model was developed and evaluated for clinical predictive ability using calibration curves, the Hosmer-Lemeshow test, and decision curve analysis (DCA). Results: Post-operative pathological upgrades were experienced by 39.3% of patients with LSIL. Independent risk factors for escalation included positive human papillomavirus (HPV)16/18/52/53/58 high-risk types (P P < 0.05, OR = 4.95, 95% CI = 1.32-18.46), ThinPrep Cytology Test (TCT) results indicating high-grade squamous intraepithelial lesion (HSIL)/atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion (ASC-H)/atypical glandular cells ( AGC) (P P < 0.01, OR = 13.12, 95% CI = 3.10-55.50), and cervical transformation zone (TZ) type III (P P < 0.05, OR = 6.10, 95% CI = 1.65-22.56). Based on these factors, the nomogram demonstrated good differentiation and calibration (area under the curve [AUC]: 0.744, 95% CI: 0.674-0.839). DCA indicated high clinical predictive value. Conclusion: HPV16/18/52/53/58 high-risk types, TCT HSIL/ASC-H/AGC, and colposcopic cervical TZ type III are independent risk factors for post-operative pathologic escalation in LSIL. Consideration of pre-operative HPV, TCT results, and cervical TZ type is crucial for effective triage and patient management. The constructed nomogram provides a practical tool for risk assessment of patients with LSIL undergoing cervical conization.
引用
收藏
页数:12
相关论文
共 22 条
[1]   Cervical Cytology-Histology Correlation Based on the American Society of Cytopathology Guideline (2017) at the Russian National Medical Research Center for Obstetrics, Gynecology, and Perinatology [J].
Asaturova, Aleksandra ;
Dobrovolskaya, Darya ;
Magnaeva, Alina ;
Tregubova, Anna ;
Bayramova, Guldana ;
Sukhikh, Gennady .
DIAGNOSTICS, 2022, 12 (01)
[2]  
Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3
[3]   Real-world safety profile of the 9-valent human papillomavirus vaccine: A study in Zhejiang, China from 2019 to 2021 [J].
Chen, Fuxing ;
Pan, Xuejiao ;
Liang, Hui ;
Shen, Lingzhi ;
Wang, Ying ;
Chen, Yaping ;
Lv, Huakun ;
Hu, Yu .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (07)
[4]   Follow up in women with biopsy diagnosis of cervical low-grade squamous intraepithelial lesion (LSIL): how long should it be? [J].
Ciavattini, Andrea ;
Clemente, Nicolo ;
Tsiroglou, Dimitrios ;
Sopracordevole, Francesco ;
Serri, Matteo ;
Delli Carpini, Giovanni ;
Papiccio, Maria ;
Cattani, Paolo .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 295 (04) :997-1003
[5]  
Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1038/bjc.2014.639, 10.7326/M14-0698, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1136/bmj.g7594, 10.1111/eci.12376, 10.1002/bjs.9736, 10.1016/j.jclinepi.2014.11.010]
[6]   Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance [J].
Huh, Warner K. ;
Ault, Kevin A. ;
Chelmow, David ;
Davey, Diane D. ;
Goulart, Robert A. ;
Garcia, Francisco A. R. ;
Kinney, Walter K. ;
Massad, L. Stewart ;
Mayeaux, Edward J. ;
Saslow, Debbie ;
Schiffman, Mark ;
Wentzensen, Nicolas ;
Lawson, Herschel W. ;
Einstein, Mark H. .
GYNECOLOGIC ONCOLOGY, 2015, 136 (02) :178-182
[7]   The role of PAX1 methylation in predicting the pathological upgrade of cervical intraepithelial neoplasia before cold knife conization [J].
Li, Mingzhu ;
Zhao, Chao ;
Zhao, Yun ;
Li, Jingran ;
Wang, Jingyuan ;
Luo, Hongxue ;
Tang, Zhijian ;
Guo, Yan ;
Wei, Lihui .
FRONTIERS IN ONCOLOGY, 2023, 12
[8]   Comparison of primary cytology, primary HPV testing and co-testing as cervical cancer screening for Chinese women: a population-based screening cohort [J].
Li, Zhi-Fang ;
Jia, Xin-Hua ;
Feng, Xiangxian ;
Zhang, Shaokai ;
Zhang, Xun ;
Pan, Qin-Jing ;
Zou, Xun-Wen ;
Hao, Yue-Qing ;
Sun, Xi-Bin ;
Qiao, You-Lin .
BMJ OPEN, 2022, 12 (10)
[9]   2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors [J].
Massad, L. Stewart ;
Einstein, Mark H. ;
Huh, Warner K. ;
Katki, Hormuzd A. ;
Kinney, Walter K. ;
Schiffman, Mark ;
Solomon, Diane ;
Wentzensen, Nicolas ;
Lawson, Herschel W. .
OBSTETRICS AND GYNECOLOGY, 2013, 121 (04) :829-846
[10]   Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study [J].
Matsumoto, Koji ;
Oki, Akinori ;
Furuta, Reiko ;
Maeda, Hiroo ;
Yasugi, Toshiharu ;
Takatsuka, Naoyoshi ;
Mitsuhashi, Akira ;
Fujii, Takuma ;
Hirai, Yasuo ;
Iwasaka, Tsuyoshi ;
Yaegashi, Nobuo ;
Watanabe, Yoh ;
Nagai, Yutaka ;
Kitagawa, Tomoyuki ;
Yoshikawa, Hiroyuki .
INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (12) :2898-2910